A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine

NCT00013897 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Atazanavir
DRUG: Lamivudine/Zidovudine
DRUG: Efavirenz

Sponsor

Bristol-Myers Squibb